Tags

Type your tag names separated by a space and hit enter

[Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders].
Fortschr Med 1977; 95(1):48-51FM

Abstract

A double blind trial was performed in a geriatric unit in order to evaluate efficacy and tolerability of Trental 400 (400 mg Pentoxifylline per tablet) against a comparative formulation (2,4 mg adenosine per tablet) in 36 patients displaying signs of peripheral vascular disease and in 16 patients with symptoms of cerebrovascular disorders. 3 tablets were administered daily over a period of three months. Trental 400 proved to be significantly more effective in either indication group. Based on the observed good tolerability and pronounced efficacy Trental 400 can be considered as an easy to handle therapeutic tool for the long term treatment of symptoms resulting from peripheral and cerebral vascular disorders.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial

Language

ger

PubMed ID

401759

Citation

Feine-Haake, G. "[Assessment of the Therapeutic Effect of Trental 400. Double-blind Study in Geriatric Patients With Circulatory Disorders]." Fortschritte Der Medizin, vol. 95, no. 1, 1977, pp. 48-51.
Feine-Haake G. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders]. Fortschr Med. 1977;95(1):48-51.
Feine-Haake, G. (1977). [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders]. Fortschritte Der Medizin, 95(1), pp. 48-51.
Feine-Haake G. [Assessment of the Therapeutic Effect of Trental 400. Double-blind Study in Geriatric Patients With Circulatory Disorders]. Fortschr Med. 1977 Jan 6;95(1):48-51. PubMed PMID: 401759.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders]. A1 - Feine-Haake,G, PY - 1977/1/6/pubmed PY - 1977/1/6/medline PY - 1977/1/6/entrez SP - 48 EP - 51 JF - Fortschritte der Medizin JO - Fortschr. Med. VL - 95 IS - 1 N2 - A double blind trial was performed in a geriatric unit in order to evaluate efficacy and tolerability of Trental 400 (400 mg Pentoxifylline per tablet) against a comparative formulation (2,4 mg adenosine per tablet) in 36 patients displaying signs of peripheral vascular disease and in 16 patients with symptoms of cerebrovascular disorders. 3 tablets were administered daily over a period of three months. Trental 400 proved to be significantly more effective in either indication group. Based on the observed good tolerability and pronounced efficacy Trental 400 can be considered as an easy to handle therapeutic tool for the long term treatment of symptoms resulting from peripheral and cerebral vascular disorders. SN - 0015-8178 UR - https://www.unboundmedicine.com/medline/citation/401759/[Assessment_of_the_therapeutic_effect_of_Trental_400__Double_blind_study_in_geriatric_patients_with_circulatory_disorders]_ L2 - https://medlineplus.gov/vasculardiseases.html DB - PRIME DP - Unbound Medicine ER -